en

PRODUCT DETAIL

VFEND 200 mg filmom obalené tablety

Code 33741
MA number EU/1/02/212/015
Product Form: tbl flm 14x200 mg (blis.PVC/Alu)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Pfizer Europe MA EEIG, Belgium
Therapeutic Class: 26 - ANTIMYCOTICA (LOKÁLNE A CELKOVÉ)
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J02 ANTIMYCOTICS FOR SYSTEMIC USE
J02A ANTIMYCOTICS FOR SYSTEMIC USE
J02AC Triazole and tetrazole derivatives
J02AC03 Voriconazole
Shelf life: 36
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application
MA issued: 19.03.2022
SmPC + PL: European Medicines Agency's database
Dokument: DHPC Vfend 26 9 2011.pdf  
Dokument: DHPV Vfend 24 6 2010.pdf  
Dokument: DHPV Vfend 24 6 2010.pdf  
Safety feature Yes
Data update: 18.05.2022
eu-flag.png sk-flag.png